COVID-19 Treatments

Action Alert: Join Children’s Health Defense in Demanding that the FDA Withdraw its Approval of Remdesivir for Children

by Children’s Health Defense The Food and Drug Administration (FDA) announced on April 25 that it expanded approval of the toxic antiviral drug, remdesivir (also known as Veklury), to treat children as young as four weeks old who are either hospitalized with COVID or are considered to be at high risk for progressing to severe

Action Alert: Join Children’s Health Defense in Demanding that the FDA Withdraw its Approval of Remdesivir for Children Read More »